vs
德康医疗（DXCM）与GRIFFON CORP（GFF）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是GRIFFON CORP的1.9倍（$1.3B vs $649.1M），德康医疗净利率更高（21.2% vs 9.9%，领先11.3%），德康医疗同比增速更快（21.6% vs 2.6%），过去两年德康医疗的营收复合增速更高（12.0% vs -1.8%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
格里芬公司是总部位于纽约的跨国多元化控股集团，业务覆盖多领域运营，旗下拥有Ames True Temper、ClosetMaid、Clopay建筑产品和CornellCookson四大子公司。该公司1961年起在纽交所公开上市，是标普小盘600指数、标普1500综合指数及罗素2000指数的成分股。
DXCM vs GFF — 直观对比
营收规模更大
DXCM
是对方的1.9倍
$649.1M
营收增速更快
DXCM
高出18.9%
2.6%
净利率更高
DXCM
高出11.3%
9.9%
两年增速更快
DXCM
近两年复合增速
-1.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $649.1M |
| 净利润 | $267.3M | $64.4M |
| 毛利率 | 62.9% | 41.1% |
| 营业利润率 | 25.6% | 17.5% |
| 净利率 | 21.2% | 9.9% |
| 营收同比 | 21.6% | 2.6% |
| 净利润同比 | 153.6% | -9.1% |
| 每股收益（稀释后） | $0.67 | $1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMGFF
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $649.1M | ||
| Q3 25 | $1.2B | $662.2M | ||
| Q2 25 | $1.2B | $613.6M | ||
| Q1 25 | $1.0B | $611.7M | ||
| Q4 24 | $1.1B | $632.4M | ||
| Q3 24 | $994.2M | $659.7M | ||
| Q2 24 | $1.0B | $647.8M |
净利润DXCMGFF
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $64.4M | ||
| Q3 25 | $283.8M | $43.6M | ||
| Q2 25 | $179.8M | $-120.1M | ||
| Q1 25 | $105.4M | $56.8M | ||
| Q4 24 | $151.7M | $70.9M | ||
| Q3 24 | $134.6M | $62.5M | ||
| Q2 24 | $143.5M | $41.1M |
毛利率DXCMGFF
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 41.1% | ||
| Q3 25 | 60.5% | 41.7% | ||
| Q2 25 | 59.5% | 43.2% | ||
| Q1 25 | 56.9% | 41.2% | ||
| Q4 24 | 58.9% | 41.8% | ||
| Q3 24 | 59.7% | 39.9% | ||
| Q2 24 | 62.4% | 38.5% |
营业利润率DXCMGFF
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 17.5% | ||
| Q3 25 | 20.1% | 18.0% | ||
| Q2 25 | 18.4% | -20.5% | ||
| Q1 25 | 12.9% | 16.5% | ||
| Q4 24 | 17.0% | 17.7% | ||
| Q3 24 | 15.3% | 16.9% | ||
| Q2 24 | 15.7% | 13.8% |
净利率DXCMGFF
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 9.9% | ||
| Q3 25 | 23.5% | 6.6% | ||
| Q2 25 | 15.5% | -19.6% | ||
| Q1 25 | 10.2% | 9.3% | ||
| Q4 24 | 13.6% | 11.2% | ||
| Q3 24 | 13.5% | 9.5% | ||
| Q2 24 | 14.3% | 6.3% |
每股收益（稀释后）DXCMGFF
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.41 | ||
| Q3 25 | $0.70 | $1.04 | ||
| Q2 25 | $0.45 | $-2.65 | ||
| Q1 25 | $0.27 | $1.21 | ||
| Q4 24 | $0.37 | $1.49 | ||
| Q3 24 | $0.34 | $1.29 | ||
| Q2 24 | $0.35 | $0.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $95.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $108.9M |
| 总资产 | $6.3B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMGFF
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $95.3M | ||
| Q3 25 | $1.8B | $99.0M | ||
| Q2 25 | $1.2B | $107.3M | ||
| Q1 25 | $904.9M | $127.8M | ||
| Q4 24 | $606.1M | $152.0M | ||
| Q3 24 | $621.2M | $114.4M | ||
| Q2 24 | $939.2M | $133.5M |
总债务DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B |
股东权益DXCMGFF
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $108.9M | ||
| Q3 25 | $2.7B | $74.0M | ||
| Q2 25 | $2.6B | $63.9M | ||
| Q1 25 | $2.3B | $214.7M | ||
| Q4 24 | $2.1B | $227.8M | ||
| Q3 24 | $2.0B | $224.9M | ||
| Q2 24 | $2.4B | $223.5M |
总资产DXCMGFF
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $2.1B | ||
| Q3 25 | $7.5B | $2.1B | ||
| Q2 25 | $7.3B | $2.1B | ||
| Q1 25 | $6.8B | $2.3B | ||
| Q4 24 | $6.5B | $2.3B | ||
| Q3 24 | $6.4B | $2.4B | ||
| Q2 24 | $6.8B | $2.4B |
负债/权益比DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 22.71× | ||
| Q1 25 | — | 7.16× | ||
| Q4 24 | — | 6.48× | ||
| Q3 24 | — | 6.78× | ||
| Q2 24 | — | 6.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $107.0M |
| 自由现金流经营现金流 - 资本支出 | — | $99.3M |
| 自由现金流率自由现金流/营收 | — | 15.3% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.66× |
| 过去12个月自由现金流最近4个季度 | — | $278.9M |
8季度趋势，按日历期对齐
经营现金流DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $107.0M | ||
| Q3 25 | $659.9M | $75.0M | ||
| Q2 25 | $303.0M | $123.1M | ||
| Q1 25 | $183.8M | $16.5M | ||
| Q4 24 | $301.4M | $142.9M | ||
| Q3 24 | $199.5M | $72.1M | ||
| Q2 24 | $279.4M | $122.1M |
自由现金流DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $99.3M | ||
| Q3 25 | $579.4M | $62.4M | ||
| Q2 25 | $208.9M | $114.4M | ||
| Q1 25 | $96.8M | $2.8M | ||
| Q4 24 | $176.8M | $125.5M | ||
| Q3 24 | $88.3M | $51.6M | ||
| Q2 24 | $213.3M | $107.5M |
自由现金流率DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 15.3% | ||
| Q3 25 | 47.9% | 9.4% | ||
| Q2 25 | 18.1% | 18.6% | ||
| Q1 25 | 9.3% | 0.5% | ||
| Q4 24 | 15.9% | 19.8% | ||
| Q3 24 | 8.9% | 7.8% | ||
| Q2 24 | 21.2% | 16.6% |
资本支出强度DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.2% | ||
| Q3 25 | 6.7% | 1.9% | ||
| Q2 25 | 8.1% | 1.4% | ||
| Q1 25 | 8.4% | 2.2% | ||
| Q4 24 | 11.2% | 2.8% | ||
| Q3 24 | 11.2% | 3.1% | ||
| Q2 24 | 6.6% | 2.2% |
现金转化率DXCMGFF
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.66× | ||
| Q3 25 | 2.33× | 1.72× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 0.29× | ||
| Q4 24 | 1.99× | 2.02× | ||
| Q3 24 | 1.48× | 1.15× | ||
| Q2 24 | 1.95× | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
GFF
| Consumer And Professional Products | $241.1M | 37% |
| Residential Repairand Remodel | $202.1M | 31% |
| International Excluding North America | $97.8M | 15% |
| Retail | $47.3M | 7% |
| Residential New Construction | $32.5M | 5% |
| Other | $14.2M | 2% |
| Industrial | $14.1M | 2% |
